Company
United StatesPublic company, NASDAQ: MCRBSeres Therapeutics Inc (NASDAQ: MCRB), Cambridge, MA – FDA Inspections
Inspection records and compliance data for Seres Therapeutics Inc in Cambridge, Massachusetts. 2 FDA inspections on record, last inspected July 29, 2025. Publicly traded as NASDAQ: MCRB.
Company Profile
This profile covers Seres Therapeutics Inc based in Cambridge, Massachusetts, United States.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 0
- VAI
- 0
- NAI
- 2
- Form 483s
- 0
- Warning letters
- 0
First inspected December 14, 2022. Last inspected July 29, 2025.
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| July 29, 2025 | NAI | Biologics · Vaccines and Allergenic Products | 1279457 |
| December 14, 2022 | NAI | Biologics · Vaccines and Allergenic Products | 1202371 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Seres Therapeutics Inc
Stock ticker
MCRB
Exchange
NASDAQ
Share price
$2.09
Market cap
$21.3M
Price as of
November 6, 2026
FEI Number
3012828816
Address
200 Sidney St # 2, Cambridge, Massachusetts 02139, United States
Country
United States
ID: 351817fa-7d0b-4438-9744-5bcb0723f106